COX-2 blockade in cancer prevention and therapy:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Totowa, N.J.
Humana Press
2003
|
| Schriftenreihe: | Cancer drug discovery and development
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | x, 371 p. ill. (some col.) : 27 cm |
| ISBN: | 1588290107 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV019403612 | ||
| 003 | DE-604 | ||
| 005 | 20060612 | ||
| 007 | t | ||
| 008 | 040927s2003 a||| |||| 00||| eng d | ||
| 020 | |a 1588290107 |c alk. paper |9 1-58829-010-7 | ||
| 035 | |a (OCoLC)49895216 | ||
| 035 | |a (DE-599)BVBBV019403612 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 | ||
| 050 | 0 | |a RC268.15 | |
| 082 | 0 | |a 616.99/4052 |2 21 | |
| 084 | |a XH 3200 |0 (DE-625)152888:12905 |2 rvk | ||
| 245 | 1 | 0 | |a COX-2 blockade in cancer prevention and therapy |c edited by Randall E. Harris |
| 246 | 1 | 3 | |a COX-two blockade in cancer prevention and therapy |
| 264 | 1 | |a Totowa, N.J. |b Humana Press |c 2003 | |
| 300 | |a x, 371 p. |b ill. (some col.) : 27 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Cancer drug discovery and development | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Anti-Inflammatory Agents, Non-Steroidal |x therapeutic use | |
| 650 | 4 | |a Cancer |x Chemoprevention | |
| 650 | 4 | |a Cyclooxygenase 2 |x Inhibitors |x Therapeutic use | |
| 650 | 4 | |a Cyclooxygenase Inhibitors |x therapeutic use | |
| 650 | 4 | |a Neoplasms |x prevention & control | |
| 650 | 4 | |a Nonsteroidal anti-inflammatory agents | |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prävention |0 (DE-588)4076308-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Prostaglandinsynthaseinhibitor |0 (DE-588)4282737-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 1 | |a Prävention |0 (DE-588)4076308-0 |D s |
| 689 | 0 | 2 | |a Prostaglandinsynthaseinhibitor |0 (DE-588)4282737-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 1 | 2 | |a Prostaglandinsynthaseinhibitor |0 (DE-588)4282737-1 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Harris, Randall E. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012865807&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-012865807 | ||
Datensatz im Suchindex
| _version_ | 1804132858779926528 |
|---|---|
| adam_text | COX-2 BLOCKADE IN CANCER PREVENTION AND THERAPY EDITED BY RANDALL E.
HARRIS, MD, PHD THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE AND SCHOOL
OF PUBLIC HEALTH, COLUMBUS, OH HUMANA PRESS TOTOWA, NEW JERSEY CONTENTS
PREFACE V CONTRIBUTORS IX PART I. HISTORICAL PERSPECTIVES 1 DIETARY
FATTY ACIDS, COX-2 BLOCKADE, AND CARCINOGENESIS 3 RASHIDA A. KARMALI 2
HISTORICAL ASPECTS OF COX-2: CLONING AND CHARACTERIZATION OF THE CDNA,
PROTEIN AND GENE 13 HARVEY R. HERSCHMAN PART II. EPIDEMIOLOGY OF NSAIDS
AND CANCER 3 EPIDEMIOLOGY OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND
COLORECTAL CANCER 35 MICHAEL J. THUN AND S. JANE HENLEY 4 EPIDEMIOLOGY
OF BREAST CANCER AND NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: EXTENSION OF
THE DIETARY FAT HYPOTHESIS OF BREAST CANCER 57 RANDALL E. HARRIS PART
III. ANIMAL MODELS OF CARCINOGENESIS 5 ROLE OF SYNTHETIC AND NATURALLY
OCCURRING CYCLOOXYGENASE INHIBITORS IN COLON CANCER PREVENTION 71
BANDARU S. REDDY AND CHINTHALAPALLY V. RAO 6 CHEMOPREVENTION OF BREAST
CANCER BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND SELECTIVE COX-2
BLOCKADE IN ANIMALS 85 HUSSEIN M. ABOU-ISSA, GALAL A. ALSHAFIE, AND
RANDALL E. HARRIS 7 THE ROLE OF CYCLOOXYGENASE-2 IN THE PREVENTION AND
THERAPY OF LUNG CANCER 99 HILDEGARD M. SCHULLER 8 NONSTEROIDAL
ANTI-INFLAMMATORY DRUGS, PROSTAGLANDINS, AND APE-DRIVEN INTESTINAL
TUMORIGENESIS 117 JAY WHELAN AND MICHAEL F. MCENTEE 9 CYCLOOXYGENASE-1
AND CYCLOOXYGENASE-2 KNOCKOUT MICE PROVIDE INSIGHTS INTO BENEFICIAL AND
ADVERSE EFFECTS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS 147 ROBERT
LANGENBACH PART IV. MOLECULAR BIOLOGY OF COX-2 10 CYCLOOXYGENASE-2,
PROSTAGLANDINS, AND COLORECTAL CARCINOGENESIS 159 RAJNISH A. GUPTA AND
RAYMOND N. DUBOIS VII VIII CONTENTS 11 REGULATION OF EXPRESSION AND
POTENTIAL CARCINOGENIC ROLE OF CYCLOOXYGENASE-2 171 BYEONG-CHURL JANG
AND TIMOTHY HLA 12 CYCLOOXYGENASE-2 AND CANCER 185 ALANE T. KOKI,
KATHLEEN M. LEAHY, JANET M. HARMON, AND JAIME L. MASFERRER 13
INTERACTIONS OF CYCLOOXYGENASE AND AROMATASE PATHWAYS IN NORMAL AND
MALIGNANT BREAST CELLS 205 JEANETTE A. RICHARDS AND ROBERT W.
BRUEGGEMEIER 14 ASSOCIATION OF COX-2 AND PPARS IN CARCINOGENESIS AND
CHEMOPREVENTION 225 TONG-CHUAN HE 15 CARCINOGENESIS INVOLVING
CYCLOOXYGENASE AND LIPOXYGENASE... 245 LINDA C. HSI AND THOMAS E. ELING
PART V. CLINICAL APPLICATIONS 16 THE DEVELOPMENT OF DRUGS THAT TARGET
CYCLOOXYGENASE-2 259 TIMOTHY MAZIASZ, K. NASIR KHAN, JOHN TALLEY, JAMES
GIERSE, AND KAREN SEIBERT 17 CHEMOPREVENTION OF CANCER BY NSAIDS AND
SELECTIVE COX-2 BLOCKADE 279 GARY J. KELLOFF, VERNON E. STEELE, AND
CAROLINE C. SIGMAN 18 POTENTIAL FOR INHIBITORS OF CYCLOOXYGENASE-2 TO
ENHANCE TUMOR RADIORESPONSE 301 RANDY BURD, HAK CHOY, AND ADAM DICKER 19
POTENTIAL ROLE OF NSAIDS AND COX-2 BLOCKADE IN CANCER THERAPY 313
WILLIAM F. ANDERSON, ASAD UMAR, JAYE L. VINER, AND ERNEST T. HAWK 20
CYCLOOXYGENASE-2 BLOCKADE IN CANCER PREVENTION AND THERAPY: WIDENING THE
SCOPE OF IMPACT 341 RANDALL E. HARRIS INDEX 367
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV019403612 |
| callnumber-first | R - Medicine |
| callnumber-label | RC268 |
| callnumber-raw | RC268.15 |
| callnumber-search | RC268.15 |
| callnumber-sort | RC 3268.15 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3200 |
| ctrlnum | (OCoLC)49895216 (DE-599)BVBBV019403612 |
| dewey-full | 616.99/4052 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99/4052 |
| dewey-search | 616.99/4052 |
| dewey-sort | 3616.99 44052 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02343nam a2200565zc 4500</leader><controlfield tag="001">BV019403612</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20060612 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">040927s2003 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1588290107</subfield><subfield code="c">alk. paper</subfield><subfield code="9">1-58829-010-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)49895216</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV019403612</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC268.15</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4052</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3200</subfield><subfield code="0">(DE-625)152888:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">COX-2 blockade in cancer prevention and therapy</subfield><subfield code="c">edited by Randall E. Harris</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">COX-two blockade in cancer prevention and therapy</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, N.J.</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">x, 371 p.</subfield><subfield code="b">ill. (some col.) : 27 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer drug discovery and development</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Inflammatory Agents, Non-Steroidal</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemoprevention</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cyclooxygenase 2</subfield><subfield code="x">Inhibitors</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cyclooxygenase Inhibitors</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">prevention & control</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nonsteroidal anti-inflammatory agents</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Prostaglandinsynthaseinhibitor</subfield><subfield code="0">(DE-588)4282737-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Prävention</subfield><subfield code="0">(DE-588)4076308-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Prostaglandinsynthaseinhibitor</subfield><subfield code="0">(DE-588)4282737-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Prostaglandinsynthaseinhibitor</subfield><subfield code="0">(DE-588)4282737-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Harris, Randall E.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012865807&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-012865807</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV019403612 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T19:59:30Z |
| institution | BVB |
| isbn | 1588290107 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-012865807 |
| oclc_num | 49895216 |
| open_access_boolean | |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | x, 371 p. ill. (some col.) : 27 cm |
| publishDate | 2003 |
| publishDateSearch | 2003 |
| publishDateSort | 2003 |
| publisher | Humana Press |
| record_format | marc |
| series2 | Cancer drug discovery and development |
| spelling | COX-2 blockade in cancer prevention and therapy edited by Randall E. Harris COX-two blockade in cancer prevention and therapy Totowa, N.J. Humana Press 2003 x, 371 p. ill. (some col.) : 27 cm txt rdacontent n rdamedia nc rdacarrier Cancer drug discovery and development Includes bibliographical references and index Anti-Inflammatory Agents, Non-Steroidal therapeutic use Cancer Chemoprevention Cyclooxygenase 2 Inhibitors Therapeutic use Cyclooxygenase Inhibitors therapeutic use Neoplasms prevention & control Nonsteroidal anti-inflammatory agents Therapie (DE-588)4059798-2 gnd rswk-swf Prävention (DE-588)4076308-0 gnd rswk-swf Prostaglandinsynthaseinhibitor (DE-588)4282737-1 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Krebs Medizin (DE-588)4073781-0 s Prävention (DE-588)4076308-0 s Prostaglandinsynthaseinhibitor (DE-588)4282737-1 s DE-604 Therapie (DE-588)4059798-2 s Harris, Randall E. Sonstige oth GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012865807&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | COX-2 blockade in cancer prevention and therapy Anti-Inflammatory Agents, Non-Steroidal therapeutic use Cancer Chemoprevention Cyclooxygenase 2 Inhibitors Therapeutic use Cyclooxygenase Inhibitors therapeutic use Neoplasms prevention & control Nonsteroidal anti-inflammatory agents Therapie (DE-588)4059798-2 gnd Prävention (DE-588)4076308-0 gnd Prostaglandinsynthaseinhibitor (DE-588)4282737-1 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4059798-2 (DE-588)4076308-0 (DE-588)4282737-1 (DE-588)4073781-0 (DE-588)4143413-4 |
| title | COX-2 blockade in cancer prevention and therapy |
| title_alt | COX-two blockade in cancer prevention and therapy |
| title_auth | COX-2 blockade in cancer prevention and therapy |
| title_exact_search | COX-2 blockade in cancer prevention and therapy |
| title_full | COX-2 blockade in cancer prevention and therapy edited by Randall E. Harris |
| title_fullStr | COX-2 blockade in cancer prevention and therapy edited by Randall E. Harris |
| title_full_unstemmed | COX-2 blockade in cancer prevention and therapy edited by Randall E. Harris |
| title_short | COX-2 blockade in cancer prevention and therapy |
| title_sort | cox 2 blockade in cancer prevention and therapy |
| topic | Anti-Inflammatory Agents, Non-Steroidal therapeutic use Cancer Chemoprevention Cyclooxygenase 2 Inhibitors Therapeutic use Cyclooxygenase Inhibitors therapeutic use Neoplasms prevention & control Nonsteroidal anti-inflammatory agents Therapie (DE-588)4059798-2 gnd Prävention (DE-588)4076308-0 gnd Prostaglandinsynthaseinhibitor (DE-588)4282737-1 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Anti-Inflammatory Agents, Non-Steroidal therapeutic use Cancer Chemoprevention Cyclooxygenase 2 Inhibitors Therapeutic use Cyclooxygenase Inhibitors therapeutic use Neoplasms prevention & control Nonsteroidal anti-inflammatory agents Therapie Prävention Prostaglandinsynthaseinhibitor Krebs Medizin Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=012865807&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT harrisrandalle cox2blockadeincancerpreventionandtherapy AT harrisrandalle coxtwoblockadeincancerpreventionandtherapy |